# OnCo record nct05862324 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05862324/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05862324", "NCT05862324" ;
  schema:name "TAC T-cells for the Treatment of Claudin 18.2 Positive Solid Tumors (TACTIC-3)"@en ;
  schema:alternateName "TACTIC-3"@en ;
  schema:description "A phase 1/2 trial of TAC01-CLDN18.2 in advanced solid tumours, run by Triumvira Immunologics, Inc., active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05862324/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05862324> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2023-08-23" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:technologies <https://onco.cc/technologies/tcr-t/> ;
  onco:drugs <https://onco.cc/drugs/tac01-cldn18-2/> ;
  onco:companies <https://onco.cc/companies/triumvira-immunologics/> .